Stay updated on AK104 Plus Anlotinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the AK104 Plus Anlotinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AK104 Plus Anlotinib in NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.3.3' was added to the record history, and 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed from the footer. These changes are administrative and do not affect study data or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-22T23:56:20.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    A new revision entry v3.3.2 has been added to the Record History, and v3.3.1 has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T10:51:53.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Record History shows a new version entry (v3.3.1) added and removal of v3.2.0, indicating routine history updates rather than substantive changes to trial details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T11:59:29.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Deleted a site-wide notice about government funding and operating status. The change does not alter the study details or history records shown on the page.
    Difference
    0.8%
    Check dated 2025-11-17T06:18:01.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The version history shows recruitment status updates on 2022-01-25, 2022-05-18, and 2025-08-14, and a study status update on 2025-02-28. No new sections were added or removed; only status fields were updated.
    Difference
    0.1%
    Check dated 2025-11-03T00:49:19.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    - Replaced version tag from v3.1.0 to v3.2.0 and added a prominent notice about government funding impact and operating status with references to NIH Clinical Center and official sources.
    Difference
    13%
    Check dated 2025-10-05T07:14:05.000Z thumbnail image

Stay in the know with updates to AK104 Plus Anlotinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AK104 Plus Anlotinib in NSCLC Clinical Trial page.